| Ticker Details |
|
Sana Biotechnology, Inc.
|
| IPO Date: |
February 1, 2021 |
| Sector: |
Healthcare |
| Industry: |
Biotech |
| Market Cap: |
$1.17B |
| Activated in VL: |
True |
| Average Daily Range |
| Avg Daily Range: |
$0.34 | 4.94%
|
| Avg Daily Range (30 D): |
$0.12 | 3.34%
|
| Avg Daily Range (90 D): |
$0.12 | 3.42%
|
| Institutional Daily Volume |
| Avg Daily Volume: |
2.03M |
| Avg Daily Volume (30 D): |
2.2M |
| Avg Daily Volume (90 D): |
3.08M |
| Trade Size |
| Avg Trade Size (Sh.): |
150 |
| Avg Trade Size (Sh.) (30 D): |
157 |
| Avg Trade Size (Sh.) (90 D): |
193 |
| Institutional Trades |
| Total Institutional Trades: |
1,602 |
| Avg Institutional Trade: |
$1.81M |
| Avg Institutional Trade (30 D): |
$1.15M |
| Avg Institutional Trade (90 D): |
$1.98M |
| Avg Institutional Trade Volume: |
.28M |
| Avg Institutional Trades (Per Day): |
1 |
| Market Closing Trades |
| Avg Closing Trade: |
$1.88M |
| Avg Closing Trade (30 D): |
$1.17M |
| Avg Closing Trade (90 D): |
$1.4M |
| Avg Closing Volume: |
284.61K |
|
|
| Financials |
| |
TTM |
Q2 2026 |
Q1 2026 |
|
Basic EPS
|
$-.76
|
$-.22
|
$-.17
|
|
Diluted EPS
|
$-.76
|
$-.22
|
$-.17
|
|
Revenue
|
$M
|
$M
|
$M
|
|
Gross Profit
|
|
|
|
|
Net Income / Loss
|
$-211.82M
|
$-63.64M
|
$-47.21M
|
|
Operating Income / Loss
|
$-218.75M
|
$-65.42M
|
$-48.61M
|
|
Cost of Revenue
|
|
|
|
|
Net Cash Flow
|
$-14.2M
|
$-26.73M
|
$11.93M
|
|
PE Ratio
|
|
|
|
|
|
|